IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Apellis Pharmaceuticals Inc 14

CUSIP: 03753UAA4 | 1 institutional holders

Quarters

Q2 2020Q1 2020Q4 2019Q3 2019
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2020

Kornitzer Capital Management Inc300,000
0.0% of portfolio›$334
StyleTurnoverLocationFiled
Kornitzer Capital Management Inc
300,000$3340.0%CoreLowShawnee Mission, KS2020-08-03